wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q50238133-29D6E184-7732-4410-A942-4A3E44AEB661
Q50238133-29D6E184-7732-4410-A942-4A3E44AEB661
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50238133-29D6E184-7732-4410-A942-4A3E44AEB661
Economic Considerations in the Use of Novel Targeted Therapies for Lung Cancer: Review of Current Literature.
P2860
Q50238133-29D6E184-7732-4410-A942-4A3E44AEB661
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50238133-29D6E184-7732-4410-A942-4A3E44AEB661
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
870de83c71d7928fdcc0e46d90ba5879ea1728d8
P2860
Cross-market cost-effectiveness analysis of erlotinib as first-line maintenance treatment for patients with stable non-small cell lung cancer